Navidea Biopharmaceuticals (NYSE:NAVB) Coverage Initiated by Analysts at StockNews.com
StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research report released on Sunday morning. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Down 93.0% Shares of NAVB stock opened at $0.00 on Friday. Navidea Biopharmaceuticals has a 52-week low of $0.00 and a 52-week high […]
StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research report released on Sunday morning. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Down 93.0% Shares of NAVB stock opened at $0.00 on Friday. Navidea Biopharmaceuticals has a 52-week low of $0.00 and a 52-week high […]
